Who
Inderjit Kaul
Director
Company insider
Files Form 4 as: Director, Minerva Neurosciences.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Nov 2025
- Last trade
- 3 Aug 2026
- Last filed
- 3 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 3 Aug 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,147 at $0.00 | filing |
| 3 Aug 2026filed 3 Aug 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,147 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,169 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,169 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —364,504 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.